Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: Vascular changes or neurodegeneration?

Age and Ageing

Volumn 39, Issue 1, 2009, Pages 8-10

  Umegaki, Hiroyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

A ; Alzheimer's disease; Dementia; Insulin; Ischemic lesions

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; INSULIN RECEPTOR; INSULINASE; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENILE PLAQUE; WHITE MATTER;

AGE OF ONSET; AGING; ALZHEIMER DISEASE; BRAIN MAPPING; COGNITION DISORDERS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 77949394652     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afp211     Document Type: Note

References (17)

1. Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999; 16: 93-112.
2. Li L, Hölscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 2007; 56: 384-402.
3. Beeri MS, Silverman JM, Davis KL et al. Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci 2005; 60: 471-5.
4. Arvanitakis Z, Schneider JA, Wilson RS et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 2006; 67: 1960-5.
5. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3: 184-90.
6. Riekse RG, Leverenz JB, McCormick W et al. Effect of vascular lesions on cognition in Alzheimer's disease: a communitybased study. J Am Geriatr Soc 2004; 52: 1442-8.
7. Akisaki T, Sakurai T, Takata T et al. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus. Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006; 22: 376-84.
8. Umegaki H, Kawamura T, Mogi N, Umemura T, Kanai A, Sano T. Glucose control levels, ischaemic brain lesions, and hyperinsulinaemia were associated with cognitive dysfunction in diabetic elderly. Age Ageing 2008; 37: 458-61.
9. Suzuki M, Umegaki H, Ieda S, Mogi N, Iguchi A. Factors associated with cognitive impairment in elderly patients with diabetes mellitus. J Am Geriatr Soc 2006; 54: 558-9.
10. Sonnen JA, Larson EB, Brickell K et al. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol 2009; 66: 315-22.
11. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004; 61: 661-6.
12. Schneider JA, Wilson RS, Cochran EJ et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003; 60: 1082-8.
13. Peters R, Beckett N, Forette F et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008; 7: 683-9.
14. Ikonomovic MD, Klunk WE, Abrahamson EE et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 2008; 131: 1630-45.
15. Novak V, Abduljalil AM, Novak P, Robitaille PM. High-resolution ultrahigh-field MRI of stroke. Magn Reson Imaging 2005; 23: 539-48.
16. Kodl CT, Franc DT, Rao JP, Anderson FS et al. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes 2008; 57: 3083-9.
17. Gouw AA, van der Flier WM, Fazekas F et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008; 39: 1414-20.